CXCR2 and atrial fibrillation: Pharmacological inhibition of CXCR2 using SB225002 prevented and even reversed hypertension‐induced AF susceptibility and atrial remodelling in SHRs, likely though the inhibition of macrophage infiltration and oxidative stress.